Sunday Oct 26 | MediLexicon
FDA Has Accepted For Filing The First Potential Once-a-Day Nasal Antihistamine
The New Drug Application for a newly formulated higher strength azelastine nasal spray has now been accepted by the Food and Drug Administration as complete for substantive review after initial evaluation.
Meda: the FDA Approves Astepro
Astepro Nasal Spray is an improvement over the marketed Astelin Nasal Spray and is better tolerated by patients using the new spray.
It is similar to the other second generation antihistamines loratadine , cetirizine and azelastine .
Meda Settles U.S. Astelin Patent Litigation with Cobalt
Meda, through its wholly owned U.S. subsidiary, Meda Pharmaceuticals Inc., has entered into a settlement agreement with Cobalt Pharmaceuticals Inc.
Registration Application For Azelastine Extra Strength Submitted To The FDA
Main Category: Allergy Also Included In: Respiratory / Asthma ; Regulatory Affairs / Drug Approvals Article Date: 05 Aug 2008 - 0:00 PDT The registration application for azelastine nasal spray in the new ...
Seeking Allergy Relief Along with the beautiful weather comes something many of us dread, allergy season. via WLOS
Meda Has Settled The U.S. Astelin(R) Patent Litigation with Apotex
STOCKHOLM, Sweden - Regulatory News: Meda , through its wholly owned U.S. subsidiary, Meda Pharmaceuticals Inc., has entered into a settlement agreement with Apotex Inc. via Earth Times